Stopping and reversing Alzheimer's at an early stage

Alzheimer's Research News

Stopping and reversing Alzheimer's at an early stage
Healthy AgingNervous SystemChronic Illness
  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 54 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 49%
  • Publisher: 53%

In the fight against Alzheimer's, researchers have developed a promising, preventative therapeutic approach. They specifically targeted the amyloid beta biomolecule, which triggers the hyperactivity of nerve cells typical of the brain disease in its early stages.

In the fight against Alzheimer's, researchers have developed a promising, preventative therapeutic approach. They specifically targeted the amyloid beta biomolecule, which triggers the hyperactivity of nerve cells typical of the brain disease in its early stages. They succeeded in developing and using a protein drug that can suppress the effects of the harmful molecule.

The results obtained on mice in the laboratory indicate that neuronal dysfunctions could even be repaired. The study was published in the journal. The researchers hope that the protein they investigated, which experts refer to as amyloid-beta-binding anticalin , can halt the progression of the serious neurodegenerative disease at an early stage.

Dr. Benedikt Zott emphasizes:"We are still a long way from a therapy that can be used in humans, but the results in animal experiments are very encouraging. The effect of completely suppressing neuronal hyperactivity in the early stages of the disease is particularly remarkable." It is still unclear whether the effect can actually be achieved in human patients outside the laboratory. In any case, a more effective form of administration of the active ingredient is currently being developed. In 2016, the active substance solanezumab, which was supposed to have a similar effect, proved to be a failure in large-scale clinical trials, but this can be explained by its different molecular structure.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceDaily /  🏆 452. in US

Healthy Aging Nervous System Chronic Illness Alzheimer's Dementia Marijuana Illegal Drugs

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Protein Discovery Suggests New Target For Early-Stage Alzheimer's DrugsProtein Discovery Suggests New Target For Early-Stage Alzheimer's DrugsThe Best in Science News and Amazing Breakthroughs
Read more »

Early Signs of Alzheimer’sEarly Signs of Alzheimer’sEarly signs of Alzheimer's include memory loss, confusion, a hard time with completing tasks, and mood changes. Consult a doctor if these symptoms arise to manage and treat the condition.
Read more »

College football teammates rally around friend diagnosed with early-onset Alzheimer's at 53College football teammates rally around friend diagnosed with early-onset Alzheimer's at 53Roughly five percent of people with Alzheimer's begin showing symptoms before 65. A Frisco man and his wife are facing the toughest battle of their lives,
Read more »

Senior living: New Alzheimer’s study generating hope of early detectionSenior living: New Alzheimer’s study generating hope of early detection“When you have 90% accuracy,” Ilene Rosenthal said, “that’s very impressive.”
Read more »

Study: New blood test can help determine if someone has early signs of Alzheimer'sStudy: New blood test can help determine if someone has early signs of Alzheimer'sThe blood test, called Precivity A-D-2, measures how much amyloid and tau a person is likely to have in their brain.
Read more »

Early Detection Of Alzheimer’s May (Only Now) Be The Next Big Opportunity In DiagnosticsEarly Detection Of Alzheimer’s May (Only Now) Be The Next Big Opportunity In DiagnosticsCEO of Posit Science, developers of the BrainHQ brain training program. Focused on digital health and bringing science to the people. Read Henry Mahncke's full executive profile here.
Read more »



Render Time: 2025-02-25 16:13:33